The series includes five modules presented by experts in the field:

1. Overview of PH: Epidemiology and pathophysiology.
   Presented by Jean M. Elwing, MD, FCCP.
2. Diagnosis and assessment of PH.
   Presented by Christopher F. Barnett, MD, MPH.
3. Treatment modalities for PAH.
   Presented by Jean M. Elwing, MD, FCCP.
4. Risk assessment and selection of appropriate therapy.
   Presented by Kelly M. Chin, MD, MSCS.
5. A closer look at vasodilator challenge and when calcium channel blocker treatment of PAH is appropriate.
   Presented by Christopher F. Barnett, MD, MPH.

The PH Boot Camp is delivered through PHA Online University, offering flexible access and a self-paced learning experience.

This activity is designed to improve knowledge, competence, performance and patient care practices by instructing front-line clinicians in the highest quality of care for patients with PH. At the conclusion of the program, participants should be able to:

1. Define key pathophysiologic and epidemiologic components of PH.
2. Accurately diagnose patients through comprehensive screening and early recognition of symptoms.
3. Evaluate the patient’s conditions, calculate risk status, and prescribe optimal long-term management, including knowing when to consult with colleagues at an established PH program.
4. Tailor comprehensive care for complex patient populations and those at varying levels of risk.

This continuing education activity is provided by AffinityCE and the Pulmonary Hypertension Association. 

 

Target Audience:

This activity has been designed for pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians. It may also be of interest to nurses, physician assistants, and other allied health professionals who help care for patients with pulmonary hypertension (PH). A statement of participation is available to other attendees.

Disclosures

AffinityCE staff, PHA staff, planners and reviewers have no relevant financial relationships with ineligible companies to disclose.

Faculty Disclosures

Disclosures are available for online viewing prior to program participation and disclosed prior to the start of each presentation.

Mitigation of Relevant Financial Relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships for faculty when present were mitigated through the peer review of content by non-conflicted reviewers prior to the commencement of the activity.

 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the PHA. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians. 

AffinityCE designates this Enduring Material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other Professionals 

All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit and the accrediting organizations. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity. 

Commercial Support 

No commercial support was provided for this activity.